Target intelligence / Profile preview

Matrix metalloproteinase-9 mRNA transcript (MMP9 mRNA)

Target
MMP9 mRNA
Molecular classification
Messenger RNA, Other
01

Overview

The Matrix metalloproteinase-9 (MMP9) mRNA transcript is the messenger RNA template that encodes the MMP9 enzyme, a secreted zinc-dependent endopeptidase involved in extracellular matrix (ECM) remodeling, tissue repair, and inflammatory signaling. Under pathological conditions, such as amyotrophic lateral sclerosis (ALS), glioblastoma, and chronic inflammatory or fibrotic disorders, MMP9 expression is aberrantly upregulated. In the central nervous system, microglia-derived MMP9 degrades neuroprotective perineuronal nets and drives neuroinflammation, leading to motor neuron vulnerability and death. Historically, targeting the MMP9 protein with small molecules or antibodies has been hindered by poor selectivity and off-target toxicities. Consequently, therapeutic strategies have shifted toward targeting the MMP9 mRNA transcript directly using RNA-targeted modalities, such as antisense oligonucleotides (ASOs) like APRTX-003 and small interfering RNAs (siRNAs). These approaches utilize sequence-specific hybridization to trigger RNase H-mediated degradation or RNA interference (RNAi) machinery, effectively knocking down MMP9 expression at the source. This precise modulation of the MMP9 pathway offers a promising avenue to slow neurodegeneration and reduce pathological tissue remodeling while minimizing off-target effects.

Other names
Matrix metallopeptidase 9 mRNAMMP-9 mRNA92 kDa gelatinase mRNAGelatinase B mRNAType V collagenase mRNANM_004994.2
02

Mechanism of action

Antisense oligonucleotide-mediated mRNA degradation, RNA interference (RNAi)-mediated mRNA cleavage, and translation inhibition

03

Biological functions

TranslationRNA splicingExtracellular matrix organizationProteolysisCell migrationNeuroinflammation
04

Disease associations

Neurodegenerative diseaseCancerInflammationOther
05

Safety considerations

Off-target hybridizationUnwanted systemic effects of MMP9 knockdownImmunogenicity of RNA-targeting delivery systemsPoor CNS penetration
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

MMP9 mRNA levelsMMP9 protein levelsNeuroinflammatory cytokinesNeurofilament light chain (NfL)

Beyond the preview

Go deeper on Matrix metalloproteinase-9 mRNA transcript (MMP9 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix metalloproteinase-9 mRNA transcript (MMP9 mRNA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call